Soliloquywp Soliloquy Lite 2.5.6 Post Editing Endpoint post_title cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.8 | $0-$5k | 2.59- |
Summary
A vulnerability, which was classified as problematic, was found in Soliloquywp Soliloquy Lite 2.5.6. This issue affects some unknown processing of the component Post Editing Endpoint. The manipulation of the argument post_title results in cross site scripting. This vulnerability was named CVE-2019-25743. The attack may be performed from remote. In addition, an exploit is available.
Details
A vulnerability, which was classified as problematic, was found in Soliloquywp Soliloquy Lite 2.5.6. Affected is some unknown functionality of the component Post Editing Endpoint. The manipulation of the argument post_title with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
WordPress Soliloquy Lite 2.5.6 contains a persistent cross-site scripting vulnerability that allows authenticated attackers to inject malicious scripts by inserting script tags in the post title field. Attackers can submit POST requests to the post editing endpoint with script payloads in the post_title parameter, which are stored and executed when users preview the post.
The weakness was presented by Unk9vvN as 47517. The advisory is shared for download at exploit-db.com. This vulnerability is traded as CVE-2019-25743 since 06/04/2026. The exploitability is told to be easy. It is possible to launch the attack remotely. Successful exploitation requires user interaction by the victim. Technical details and a public exploit are known. The MITRE ATT&CK project declares the attack technique as T1059.007.
The exploit is shared for download at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.9VulDB Meta Temp Score: 4.8
VulDB Base Score: 3.5
VulDB Temp Score: 3.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.4
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
06/04/2026 Advisory disclosed06/04/2026 CVE reserved
06/04/2026 VulDB entry created
06/04/2026 VulDB entry last update
Sources
Advisory: 47517Researcher: Unk9vvN
Status: Not defined
CVE: CVE-2019-25743 (🔒)
GCVE (CVE): GCVE-0-2019-25743
GCVE (VulDB): GCVE-100-368328
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 06/04/2026 16:00Changes: 06/04/2026 16:00 (80)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.